These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 233680

  • 1. Effect of indomethacin on the hypothalamic-pituitary-adrenal axis in man.
    Beirne J, Jubiz W.
    J Clin Endocrinol Metab; 1978 Oct; 47(4):713-6. PubMed ID: 233680
    [Abstract] [Full Text] [Related]

  • 2. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT, Simonson DC.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [Abstract] [Full Text] [Related]

  • 3. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
    Grottoli S, Giordano R, Maccagno B, Pellegrino M, Ghigo E, Arvat E.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
    [Abstract] [Full Text] [Related]

  • 4. Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging.
    Wilkinson CW, Peskind ER, Raskind MA.
    Neuroendocrinology; 1997 Jan; 65(1):79-90. PubMed ID: 9032777
    [Abstract] [Full Text] [Related]

  • 5. Evidence that the central noradrenergic and adrenergic pathways activate the hypothalamic-pituitary-adrenal axis in the sheep.
    Liu JP, Clarke IJ, Funder JW, Engler D.
    Endocrinology; 1991 Jul; 129(1):200-9. PubMed ID: 1647297
    [Abstract] [Full Text] [Related]

  • 6. Hypothalamic-pituitary-adrenal axis following glucocorticoid prophylaxis against acute mountain sickness.
    Basu M, Sawhney RC, Kumar S, Pal K, Prasad R, Selvamurthy W.
    Horm Metab Res; 2002 Jun; 34(6):318-24. PubMed ID: 12173072
    [Abstract] [Full Text] [Related]

  • 7. Pituitary function tests: comparison of ACTH and 11-deoxy-cortisol responses in the metyrapone test and with the insulin hypoglycemia test.
    Steiner H, Bähr V, Exner P, Oelkers PW.
    Exp Clin Endocrinol; 1994 Jun; 102(1):33-8. PubMed ID: 8005206
    [Abstract] [Full Text] [Related]

  • 8. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
    [Abstract] [Full Text] [Related]

  • 9. Altered hypothalamic-pituitary-adrenal responsiveness to dexamethasone-insulin tolerance test in active acromegaly.
    Hofeldt FD, Levin SR, Von Werder K, Becker N, Schneider V, Hane S, Seymour R, Adams JE, Forsham PH.
    J Clin Endocrinol Metab; 1975 Aug; 41(2):399-401. PubMed ID: 1159053
    [Abstract] [Full Text] [Related]

  • 10. Naloxone-induced activation of the hypothalamic-pituitary-adrenal axis in suspected central adrenal insufficiency.
    Blevins LS, Dobs AS, Wand GS.
    Am J Med Sci; 1994 Sep; 308(3):167-70. PubMed ID: 8074133
    [Abstract] [Full Text] [Related]

  • 11. Feedback sensitivity of the rat hypothalamo-pituitary-adrenal axis and its capacity to adjust to exogenous corticosterone.
    Akana SF, Scribner KA, Bradbury MJ, Strack AM, Walker CD, Dallman MF.
    Endocrinology; 1992 Aug; 131(2):585-94. PubMed ID: 1322275
    [Abstract] [Full Text] [Related]

  • 12. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M, Allolio B, Würth G, Winkelmann W.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [Abstract] [Full Text] [Related]

  • 13. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
    Calogero AE, Kamilaris TC, Johnson EO, Tartaglia ME, Chrousos G.
    Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
    [Abstract] [Full Text] [Related]

  • 14. Effect of two prostaglandin synthesis inhibitors, indomethacin and acetylsalicylic acid, on plasma ACTH and cortisol levels in man.
    Cavagnini F, Di Landro A, Maraschini C, Invitti C, Pinto ML.
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):666-73. PubMed ID: 227205
    [Abstract] [Full Text] [Related]

  • 15. Exercise-induced activation of the hypothalamic-pituitary-adrenal axis: marked differences in the sensitivity to glucocorticoid suppression.
    Petrides JS, Mueller GP, Kalogeras KT, Chrousos GP, Gold PW, Deuster PA.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):377-83. PubMed ID: 8045951
    [Abstract] [Full Text] [Related]

  • 16. Site and mode of action of indomethacin on the hypothalamo-hypophyseal-adrenal axis: a temporal study in intact, hypothalamic-deafferentated, and hypothalamic-lesioned male rats.
    Weidenfeld J, Siegel RA, Conforti N, Feldman S, Chowers I.
    Endocrinology; 1981 Jul; 109(1):205-9. PubMed ID: 6263585
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
    Muret L, Priou A, Oliver C, Grino M.
    Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256
    [Abstract] [Full Text] [Related]

  • 18. Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans.
    Fruehwald-Schultes B, Kern W, Bong W, Wellhoener P, Kerner W, Born J, Fehm HL, Peters A.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3041-6. PubMed ID: 10487662
    [Abstract] [Full Text] [Related]

  • 19. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.
    Berneis K, Staub JJ, Gessler A, Meier C, Girard J, Müller B.
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339
    [Abstract] [Full Text] [Related]

  • 20. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.